ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

abbvie limited - adalimumab 50 mg/ml;  ;   - solution for injection - 20mg/0.4ml - active: adalimumab 50 mg/ml     excipient: citric acid monohydrate dibasic sodium phosphate dihydrate mannitol monobasic sodium phosphate dihydrate polysorbate 80 sodium chloride sodium citrate sodium hydroxide water for injection - humira in combination with methotrexate is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients aged 2 years of age and older. humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

abbvie limited - adalimumab 50 mg/ml;  ;   - solution for injection - 40 mg/0.8ml - active: adalimumab 50 mg/ml     excipient: citric acid monohydrate dibasic sodium phosphate dihydrate dimeticone mannitol monobasic sodium phosphate dihydrate polysorbate 80 sodium chloride sodium citrate dihydrate sodium hydroxide water for injection - rheumatoid arthritis humira is indicated for reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. this includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate. humira can be used alone or in combination with methotrexate.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

abbvie limited - adalimumab 50 mg/ml;  ;   - solution for injection - 40 mg/0.8ml - active: adalimumab 50 mg/ml     excipient: citric acid monohydrate dibasic sodium phosphate dihydrate dimeticone mannitol monobasic sodium phosphate dihydrate polysorbate 80 sodium chloride sodium citrate dihydrate sodium hydroxide water for injection - rheumatoid arthritis humira is indicated for reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. this includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate. humira can be used alone or in combination with methotrexate.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

abbvie limited - adalimumab 50 mg/ml;  ;   - solution for injection - 10 mg/0.2 ml - active: adalimumab 50 mg/ml     excipient: citric acid monohydrate dibasic sodium phosphate dihydrate mannitol monobasic sodium phosphate dihydrate polysorbate 80 sodium chloride sodium citrate sodium hydroxide water for injection - humira in combination with methotrexate is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients aged 2 years of age and older. humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

abbvie limited - levobupivacaine hydrochloride - solution for injection/infusion - 2.5 milligram(s)/millilitre - amides; levobupivacaine

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

abbvie limited - levobupivacaine hydrochloride - solution for injection/infusion - 5.0 milligram(s)/millilitre - amides; levobupivacaine

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

abbvie limited - levobupivacaine hydrochloride - solution for injection/infusion - 7.5 milligram(s)/millilitre - amides; levobupivacaine

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

abbvie limited - glecaprevir 100mg;  ; pibrentasvir 40mg;   - film coated tablet - active: glecaprevir 100mg   pibrentasvir 40mg   excipient: colloidal silicon dioxide copovidone croscarmellose sodium hypromellose iron oxide red lactose monohydrate macrogol 3350 propylene glycol monocaprylate sodium stearyl fumarate titanium dioxide tocofersolan - maviret is indicated for the treatment of adults and adolescents 12 years and older with chronic hepatitis c virus (hcv)

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

abbvie limited - levobupivacaine hydrochloride - solution for infusion - 0.625 milligram(s)/millilitre - amides; levobupivacaine

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

abbvie limited - dexamethasone 700ug - intraocular implant - 700 mcg - active: dexamethasone 700ug excipient: polyglactin (poly (d, l-lactide-co-glycolide), 50:50 plga acid) polyglactin - ozurdex® is indicated for the treatment of macular oedema due to retinal vein occlusion (rvo).